Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenazopyridine for Ureteral Patency Confirmation
NCT02424149Completed
- Sponsor
- Hartford Hospital
- Start
- Apr 2015
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of phenazopyridine (2 arms), sponsored by Hartford Hospital. Primary endpoint: Time to Visualize Ureteral Urine Flow Intraoperatively. Started Apr 2015; status: completed.
02
Drugs
phenazopyridine
Beyond the preview
Go deeper on NCT02424149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02424149.